New cut-off points of PHQ-9 and its variants, in Costa Rica: a nationwide observational study.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
31 08 2023
31 08 2023
Historique:
received:
13
01
2023
accepted:
28
08
2023
medline:
4
9
2023
pubmed:
1
9
2023
entrez:
31
8
2023
Statut:
epublish
Résumé
The PHQ-9 questionnaire is a screening test worldwide used to measure depression. But it cannot be used in Costa Rica, due to the fact that it has not previously been validated for its population. The present study aims to show the validation of the PHQ-9 questionnaire and its variants (PHQ-2, PHQ-4, PHQ-8) in a population sample of adults residing in Costa Rica. A sample was collected (n = 1162) using a self-administered questionnaire. Confirmatory Factor Analysis (CFA), Receiver Operating Characteristic (ROC) curve, and Multiple Group Confirmatory Factor Analysis (MGCFA) were tested. One factor was found that explained 73.33% of the variance with excellent internal consistency (α = 0.928). Goodness-of-fit measures were adequate (RMSEA = 0.107; CFI = 0.948), as was diagnostic power at a cut-off of 10 (78.60 for Sensitivity and 27.95 for 1-Specificity). External validation indices were good (r = 0.843 with GAD-7, r = - 0.647 with RS14, and r = 0.301 with FCV19S), and the model showed invariance by sex (∆χ
Identifiants
pubmed: 37652965
doi: 10.1038/s41598-023-41560-0
pii: 10.1038/s41598-023-41560-0
pmc: PMC10471633
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
14295Informations de copyright
© 2023. Springer Nature Limited.
Références
Gen Hosp Psychiatry. 2016 Mar-Apr;39:24-31
pubmed: 26719105
Psychiatry Res. 2020 Nov;293:113350
pubmed: 32777619
J Affect Disord. 2020 Nov 1;276:220-233
pubmed: 32697702
Clin Nurs Res. 2018 Jun;27(5):617-637
pubmed: 27385515
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
J Clin Psychol. 2017 Sep;73(9):1076-1090
pubmed: 28195649
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Rev Peru Med Exp Salud Publica. 2012 Oct-Dec;29(4):578-9
pubmed: 23338650
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Health Qual Life Outcomes. 2020 Jul 20;18(1):242
pubmed: 32690060
Pediatrics. 2010 May;125(5):e1097-103
pubmed: 20368315
Front Psychiatry. 2022 Dec 19;13:1059150
pubmed: 36601524
BMC Psychiatry. 2022 Mar 1;22(1):154
pubmed: 35232409
Front Psychiatry. 2021 Nov 04;12:761964
pubmed: 34803770
Int J Ment Health Addict. 2022;20(3):1537-1545
pubmed: 32226353
Indian J Cancer. 2020 Apr-Jun;57(2):212-215
pubmed: 32445328
BMC Psychiatry. 2022 Jul 11;22(1):461
pubmed: 35818021
Lancet. 2005 Jul 9-15;366(9480):111-2
pubmed: 16010710
Am J Epidemiol. 2006 Apr 1;163(7):670-5
pubmed: 16410346
BMC Psychiatry. 2021 Jul 15;21(1):356
pubmed: 34266400
Psychosomatics. 2009 Nov-Dec;50(6):613-21
pubmed: 19996233
Psychother Psychosom. 2021;90(3):160-177
pubmed: 33166960
Lancet Psychiatry. 2022 Feb;9(2):137-150
pubmed: 35026139
Gen Hosp Psychiatry. 2013 Nov-Dec;35(6):592-7
pubmed: 24029431
BMC Psychiatry. 2020 Oct 1;20(1):480
pubmed: 33004042
Behav Res Methods. 2022 Dec;54(6):2665-2677
pubmed: 34918226
Psychol Methods. 2011 Jun;16(2):209-20
pubmed: 21500916
Rev Panam Salud Publica. 2022 Aug 17;46:e79
pubmed: 35990526
Assessment. 2022 Dec;29(8):1901-1916
pubmed: 34372690
J Psychosoc Nurs Ment Health Serv. 2009 Dec;47(12):28-33
pubmed: 20000280
BJPsych Open. 2016 Mar 9;2(2):127-138
pubmed: 27703765
Behav Res Methods. 2006 Feb;38(1):88-91
pubmed: 16817517
Psychosom Med. 2001 Jul-Aug;63(4):679-86
pubmed: 11485122
Neurosci Biobehav Rev. 2020 Nov;118:669-680
pubmed: 32882313
Front Psychol. 2019 Aug 06;10:1713
pubmed: 31447721
Epidemiol Serv Saude. 2017 Jul-Sep;26(3):649-659
pubmed: 28977189
Psicothema. 2022 Feb;34(1):7-17
pubmed: 35048890
World Psychiatry. 2018 Feb;17(1):76-89
pubmed: 29352539
Actas Dermosifiliogr (Engl Ed). 2021 May;112(5):484-485
pubmed: 33253649
PLoS One. 2022 Jan 27;17(1):e0263027
pubmed: 35085349
Lancet. 2022 Mar 5;399(10328):957-1022
pubmed: 35180424
Int J Psychiatry Med. 2016 Aug;51(6):508-520
pubmed: 28629295
Cogn Neurosci. 2021 Jul-Oct;12(3-4):103-105
pubmed: 34587872
Rev Med Chil. 2018 Apr;146(4):479-486
pubmed: 29999123
Int J Environ Res Public Health. 2021 Apr 22;18(9):
pubmed: 33922281
Rev Med Chil. 2019;147(1):53-60
pubmed: 30848765
Ann Intern Med. 2021 May;174(5):ITC65-ITC80
pubmed: 33971098
Mol Psychiatry. 2022 Jan;27(1):281-295
pubmed: 34079068
PLoS One. 2018 Feb 23;13(2):e0193356
pubmed: 29474410
Sci Prog. 2022 Oct-Dec;105(4):368504221135469
pubmed: 36373774
Ann Intern Med. 2007 Mar 6;146(5):317-25
pubmed: 17339617
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
Med Care. 2003 Nov;41(11):1284-92
pubmed: 14583691
J Affect Disord. 2022 Apr 15;303:306-314
pubmed: 35181387
BMJ. 2021 Oct 5;375:n2183
pubmed: 34610915
BMC Psychiatry. 2017 Aug 9;17(1):291
pubmed: 28793892
Front Psychol. 2022 May 10;13:900535
pubmed: 35619795
J Med Internet Res. 2020 Sep 4;22(9):e22227
pubmed: 32886066